49 related articles for article (PubMed ID: 24582303)
1. Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.
Beal K; Abrey LE; Gutin PH
Radiat Oncol; 2011 Jan; 6():2. PubMed ID: 21214925
[TBL] [Abstract][Full Text] [Related]
2. Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).
Gately L; Mesía C; Sepúlveda JM; Del Barco S; Pineda E; Gironés R; Fuster J; Dumas M; Gill S; Navarro LM; Herrero A; Dowling A; de Las Peñas R; Vaz MA; Alonso M; Lwin Z; Harrup R; Peralta S; Long A; Perez-Segura P; Ahern E; Garate CO; Wong M; Campbell R; Cuff K; Jennens R; Gallego O; Underhill C; Martinez-Garcia M; Covela M; Cooper A; Brown S; Rosenthal M; Torres J; Collins IM; Gibbs P; Balana C
J Neurooncol; 2024 Jun; 168(2):299-306. PubMed ID: 38630385
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma in the elderly: treatment patterns and survival.
Pretanvil JA; Salinas IQ; Piccioni DE
CNS Oncol; 2017 Jan; 6(1):19-28. PubMed ID: 28001088
[TBL] [Abstract][Full Text] [Related]
4. In Reply to the Letter to the Editor Regarding "Palliative Care Effects on Survival in Glioblastoma: Who Receives Palliative Care?".
Pando A
World Neurosurg; 2023 May; 173():296. PubMed ID: 37189316
[No Abstract] [Full Text] [Related]
5. Palliative care in glioblastoma patients: a systematic review.
Coronatto LH; Formentin C
Rev Assoc Med Bras (1992); 2024; 70(suppl 1):e2024S122. PubMed ID: 38865542
[No Abstract] [Full Text] [Related]
6. Letter to the Editor Regarding: "Palliative Care Effects on Survival in Glioblastoma: Who Receives Palliative Care?".
Shlobin NA; Bernstein M
World Neurosurg; 2023 May; 173():294-295. PubMed ID: 37189315
[No Abstract] [Full Text] [Related]
7. Radiotherapy for glioblastoma patients with poor performance status.
Schröder C; Gramatzki D; Vu E; Guckenberger M; Andratschke N; Weller M; Hertler C
J Cancer Res Clin Oncol; 2022 Aug; 148(8):2127-2136. PubMed ID: 34448057
[TBL] [Abstract][Full Text] [Related]
8. Treating glioblastoma patients with poor performance status: where do we go from here?
Gállego Pérez-Larraya J; Ducray F
CNS Oncol; 2014 May; 3(3):231-41. PubMed ID: 25055131
[TBL] [Abstract][Full Text] [Related]
9. Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme.
Kovic B; Xie F
J Clin Oncol; 2015 Jul; 33(20):2296-302. PubMed ID: 26014296
[TBL] [Abstract][Full Text] [Related]
10. [Association of radiotherapy and chemotherapy-targeted therapies in glioblastomas].
Laigle-Donadey F; Dehais C; Mazeron JJ; Sanson M
Bull Cancer; 2009 Mar; 96(3):291-7. PubMed ID: 19318307
[TBL] [Abstract][Full Text] [Related]
11. Patterns of care and survival of glioblastoma patients: a comparative study between 2004 and 2008 in Lyon, France.
Badaoui N; Meyronet D; Cartalat-Carel S; Guyotat J; Jouanneau E; d'Hombres A; Sunyach MP; Jouvet A; Louis-Tisserand G; Archinet A; Frappaz D; Bauchet L; Honnorat J; Ducray F
Rev Neurol (Paris); 2014 Mar; 170(3):222-7. PubMed ID: 24582303
[TBL] [Abstract][Full Text] [Related]
12. [Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab].
Vauleon E; Mesbah H; Gedouin D; Lecouillard I; Louvel G; Hamlat A; Riffaud L; Carsin B; Quillien V; Audrain O; Lesimple T
Bull Cancer; 2012 Feb; 99(2):121-6. PubMed ID: 22257744
[TBL] [Abstract][Full Text] [Related]
13. Management of glioblastoma: comparison of clinical practices and cost-effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospital.
Diebold G; Ducray F; Henaine AM; Frappaz D; Guyotat J; Cartalat-Carel S; Breant V; Fouquet A; Aulagner G; Honnorat J; Armoiry X
J Clin Pharm Ther; 2014 Dec; 39(6):642-8. PubMed ID: 25164371
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH
Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.
Chinot OL; Wick W; Mason W; Henriksson R; Saran F; Nishikawa R; Carpentier AF; Hoang-Xuan K; Kavan P; Cernea D; Brandes AA; Hilton M; Abrey L; Cloughesy T
N Engl J Med; 2014 Feb; 370(8):709-22. PubMed ID: 24552318
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]